IC
RMD icon

Inscription Capital’s ResMed RMD Stock Holding History

Inscription Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
3,095
+1
+0% +$207 0.05% 337
2026
Q1 		$695K Buy
3,094
+1,392
+82% +$347K 0.07% 273
2025
Q4 		$410K Sell
1,702
-432
-20% -$110K 0.04% 413
2025
Q3 		$584K Buy
2,134
+668
+46% +$182K 0.06% 311
2025
Q2 		$378K Buy
+1,466
New +$350K 0.05% 292

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Inscription Capital's RMD Position: Q2 2026 in Review

Inscription Capital increased its ResMed (RMD) stake by 0.03% in Q2 2026, buying an estimated $207 and bringing the position to 3,095 shares worth $603K. The position accounts for 0.05% of the portfolio, ranked #337.

Inscription Capital first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $695K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Inscription Capital held 3,095 shares of ResMed worth $603K as of Q2 2026.
  • Inscription Capital bought 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up 0.05% of Inscription Capital's portfolio in Q2 2026, its #337 holding.
  • Inscription Capital first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Inscription Capital's ResMed position peaked at $695K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.